Healthlinx said this week that CEO Nick Gatsios will resign as of June 30, 2012.
Gatsios was a founding director of the company when it launched in 2002 and has been its CEO since it went public on the Australian Stock Exchange in 2006. He is extending his contracted notice period by two months in order “to complete current projects of strategic importance,” the company said.
No reason was given for his departure.
Agilent this week appointed Ron Nersesian executive vice president and chief operating officer.
Prior to the appointment, Nersesian had been president of Agilent’s Electronic Measurement Group.
Sparton Corporation’s board of directors this week named Charles Kummeth an independent director.
Kummeth is president of Thermo Fisher Scientific’s Global Chromatography and Mass Spectrometry division.